Achieve Highly Sensitive Viral Detection with the SARS-CoV-2 NGS Assay - RUO

As SARS-CoV-2 continues to evolve, there is a continued need for research and testing technologies that are better suited to dealing with these novel viruses.

Twist’s hybrid capture system and custom SARS-CoV-2 NGS Assay – RUO, combined with Biotia’s COVID-DX software, represents a powerful new advancement in viral surveillance research.

Download this application focus to learn about:

• The end-to-end SARS-CoV-2 NGS assay workflow
• Benefits of hybrid-capture technology and COVID-DX software
• How target enrichment leads to more even coverage across the entire genome